Learning Objectives
- Review the recent and updated CCS Lipid Guidelines.
- Understand the pharmacological approaches to lower LDL-C and how to tailor therapy based on individual patient profiles.
- Appreciate the value of fasting vs. non-fasting lipid assessments.
- Use case-based illustrations of how the guidelines can be applied to practice.
Chair
Peter J Lin
MD, CCFP
Director, Primary Care Initiative Canadian Heart Research Centre
Medical Director, LinCorp Medical Inc.
Faculty
Robert A Hegele
MD, FRCPC, FACP, FAHA, FCAHS
Jacob J. Wolfe Distinguished Medical Research Chair in Human Gene Function
Edith Schulich Vinet Canada Research Chair in Human Genetics
Martha Blackburn Chair in Cardiovascular Research
Distinguished University Professor of Medicine and Biochemistry, University of Western Ontario
Harpreet Singh Bajaj
MD, MPH, ECNU, FACE
Clinical Endocrinologist, LMC Diabetes & Endocrinology, Brampton
Tariff Chairman, Section of Endocrinology, Ontario Medical Association
Founding Chairman, “STOP Diabetes” Foundation Inc.
Subodh Verma
MD, PhD, FRCSC, FAHA
Division of Cardiac Surgery, St. Michael’s Hospital
Professor of Surgery, Pharmacology & Toxicology, University of Toronto Canada
Research Chair in Atherosclerosis
Video Information
- Credit:No Credit Available
- Post Date:September 19, 2016
- Expiry Date:N/A
